Wheezo from Respiri set to go on sale.
Respiri Limited (ASX:RSH) has achieved TGA approval to list its wheezo asthma monitoring device (pictured) on the Australian Therapeutics Goods Register (ARTG). The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease. TGA approval came after the Melbourne company undertook an…